| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellularly ATP-gated monoatomic cation channel activity | 2.25e-10 | 7 | 130 | 5 | GO:0004931 | |
| GeneOntologyMolecularFunction | ATP-gated ion channel activity | 1.34e-09 | 9 | 130 | 5 | GO:0035381 | |
| GeneOntologyMolecularFunction | protein kinase activity | CDC42BPG DDR1 CDC42BPA CAMK1D MYLK GRK7 NTRK2 NTRK3 HIPK2 WNK1 CDC42BPB GRK1 TXK MST1R BTK PRKCH EIF2AK2 EIF2AK3 | 6.93e-08 | 600 | 130 | 18 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDC42BPG DDR1 CDC42BPA CAMK1D MYLK GRK7 NTRK2 NTRK3 HIPK2 PFKM WNK1 CDC42BPB GRK1 TXK MST1R BTK PRKCH EIF2AK2 EIF2AK3 | 1.69e-07 | 709 | 130 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 2.61e-07 | 22 | 130 | 5 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 2.61e-07 | 22 | 130 | 5 | GO:0001614 | |
| GeneOntologyMolecularFunction | kinase activity | CDC42BPG DDR1 CDC42BPA CAMK1D MYLK GRK7 NTRK2 NTRK3 HIPK2 PFKM WNK1 CDC42BPB GRK1 TXK MST1R BTK PRKCH EIF2AK2 EIF2AK3 | 5.27e-07 | 764 | 130 | 19 | GO:0016301 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 4.90e-06 | 145 | 130 | 8 | GO:0004713 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 8.55e-06 | 43 | 130 | 5 | GO:0005231 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDC42BPG DDR1 CDC42BPA CAMK1D MYLK GRK7 NTRK2 NTRK3 HIPK2 PFKM WNK1 CDC42BPB GRK1 TXK MST1R BTK PRKCH EIF2AK2 EIF2AK3 | 1.05e-05 | 938 | 130 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDC42BPG CDC42BPA CAMK1D MYLK GRK7 HIPK2 WNK1 CDC42BPB GRK1 PRKCH EIF2AK2 EIF2AK3 | 3.55e-05 | 446 | 130 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | rhodopsin kinase activity | 1.26e-04 | 3 | 130 | 2 | GO:0050254 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.47e-04 | 77 | 130 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | neurotrophin receptor activity | 4.15e-04 | 5 | 130 | 2 | GO:0005030 | |
| GeneOntologyMolecularFunction | eukaryotic translation initiation factor 2alpha kinase activity | 6.20e-04 | 6 | 130 | 2 | GO:0004694 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | CDC42BPG CDC42BPA CAMK1D HIPK2 WNK1 CDC42BPB PRKCH EIF2AK2 EIF2AK3 | 6.28e-04 | 363 | 130 | 9 | GO:0106310 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 8.54e-04 | 65 | 130 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | translation termination factor activity | 8.65e-04 | 7 | 130 | 2 | GO:0008079 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 8.65e-04 | 7 | 130 | 2 | GO:0004703 | |
| GeneOntologyMolecularFunction | translation release factor activity | 8.65e-04 | 7 | 130 | 2 | GO:0003747 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 1.18e-03 | 247 | 130 | 7 | GO:0000287 | |
| GeneOntologyMolecularFunction | translation initiation factor binding | 2.08e-03 | 39 | 130 | 3 | GO:0031369 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.24e-03 | 140 | 130 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.31e-03 | 85 | 130 | 4 | GO:0019199 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | ADCY10 SEMA6C DOCK4 CACNA1C NTRK3 PFN2 WNK1 SHANK3 SLC12A5 SPTBN5 P2RX1 P2RX4 CLCN6 P2RX7 TENM1 MMP2 CTTN HCLS1 RBFOX2 | 7.90e-09 | 618 | 127 | 19 | GO:0090066 |
| GeneOntologyBiologicalProcess | positive regulation of transport | CACNA1C FLNA RAP1GAP CAMK1D MYLK CD2AP COLEC10 PFKM WNK1 SHANK3 TNFSF11 MALRD1 P2RX1 P2RX3 P2RX4 P2RX7 SYNJ1 CADPS BTK TENM1 SCP2 ABCB11 HSPA2 HCLS1 | 3.95e-08 | 1081 | 127 | 24 | GO:0051050 |
| GeneOntologyBiologicalProcess | purinergic nucleotide receptor signaling pathway | 1.69e-06 | 33 | 127 | 5 | GO:0035590 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | ADCY10 SEMA6C NTRK3 PFN2 WNK1 SHANK3 SLC12A5 SPTBN5 CLCN6 P2RX7 TENM1 CTTN HCLS1 | 2.34e-06 | 426 | 127 | 13 | GO:0032535 |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 3.00e-06 | 192 | 127 | 9 | GO:0034767 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | FLNA RAP1GAP WNT1 NTRK2 NTRK3 PFN2 CLIP1 SHANK3 DRG1 SPTBN5 P2RX4 P2RX7 SACS METTL18 BTK TENM1 PRKCH CTTN TACSTD2 HSPA2 EIF2AK2 HCLS1 | 3.33e-06 | 1189 | 127 | 22 | GO:0044087 |
| GeneOntologyBiologicalProcess | response to ATP | 4.53e-06 | 40 | 127 | 5 | GO:0033198 | |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 5.79e-06 | 42 | 127 | 5 | GO:0006884 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 5.98e-06 | 266 | 127 | 10 | GO:0043270 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 6.02e-06 | 112 | 127 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | muscle contraction | ADCY10 DOCK4 CACNA1C FLNA MYL1 MYLK P2RX1 P2RX3 P2RX4 P2RX6 MYL6B CTTN | 6.94e-06 | 400 | 127 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | muscle system process | ADCY10 DOCK4 CACNA1C FLNA MYL1 MYLK GTF2IRD2B P2RX1 P2RX3 P2RX4 P2RX6 MYL6B GTF2IRD2 CTTN | 7.17e-06 | 547 | 127 | 14 | GO:0003012 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | ADCY10 CDC42BPG DDR1 CDC42BPA CAMK1D NTRK2 NTRK3 HIPK2 PFN2 WNK1 CDC42BPB METAP1 METTL18 BTK TENM1 PRKCH PPIL2 EIF2AK3 HCLS1 | 8.29e-06 | 976 | 127 | 19 | GO:0018193 |
| GeneOntologyBiologicalProcess | regulation of cell size | 1.08e-05 | 225 | 127 | 9 | GO:0008361 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 1.25e-05 | 174 | 127 | 8 | GO:1904064 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ADCY10 SEMA6C FLNA DDR1 RAP1GAP CAMK1D WNT1 NTRK2 NTRK3 PFN2 CLIP1 SHANK3 P2RX4 P2RX7 TENM1 CTTN TACSTD2 | 2.24e-05 | 863 | 127 | 17 | GO:0031344 |
| GeneOntologyBiologicalProcess | action potential | 3.52e-05 | 201 | 127 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | actin filament-based process | ADCY10 CACNA1C CDC42BPG FLNA MYL1 CDC42BPA CD2AP MYOM3 PFN2 CDC42BPB SHANK3 SPTBN5 MYL6B TENM1 CTTN TACSTD2 HCLS1 | 4.48e-05 | 912 | 127 | 17 | GO:0030029 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 4.77e-05 | 154 | 127 | 7 | GO:0051928 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 4.97e-05 | 273 | 127 | 9 | GO:0034764 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | CACNA1C DDR1 RAP1GAP CAMK1D DOCK8 WNT1 NTRK2 NTRK3 HIPK2 PFN2 SHANK3 MST1R TNFSF11 P2RX1 P2RX7 BTK TENM1 PRKCH HSPA2 EIF2AK2 EIF2AK3 RIC1 | 5.83e-05 | 1430 | 127 | 22 | GO:0044093 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 5.84e-05 | 109 | 127 | 6 | GO:1904427 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ADCY10 SEMA6C FLNA DDR1 RAP1GAP CAMK1D WNT1 NTRK2 NTRK3 PFN2 CLIP1 SHANK3 P2RX4 P2RX7 TENM1 TACSTD2 | 6.44e-05 | 846 | 127 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 7.87e-05 | 115 | 127 | 6 | GO:0018107 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | ADCY10 CACNA1C FLNA CD2AP PFN2 SHANK3 SPTBN5 TENM1 CTTN TACSTD2 HCLS1 | 8.54e-05 | 438 | 127 | 11 | GO:0032970 |
| GeneOntologyBiologicalProcess | hindbrain radial glia guided cell migration | 9.83e-05 | 15 | 127 | 3 | GO:0021932 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane depolarization | 1.20e-04 | 16 | 127 | 3 | GO:1904181 | |
| GeneOntologyBiologicalProcess | positive regulation of prostaglandin secretion | 1.20e-04 | 16 | 127 | 3 | GO:0032308 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 1.22e-04 | 307 | 127 | 9 | GO:0018105 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 1.25e-04 | 125 | 127 | 6 | GO:0018210 | |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 1.28e-04 | 42 | 127 | 4 | GO:0060402 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.55e-04 | 130 | 127 | 6 | GO:0060079 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 1.62e-04 | 319 | 127 | 9 | GO:0018209 | |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | 1.66e-04 | 251 | 127 | 8 | GO:0060491 | |
| GeneOntologyBiologicalProcess | secretion | CACNA1C DDR1 PTGES2 NTRK2 CD2AP PFKM PFN2 WNK1 TNFSF11 MALRD1 P2RX1 P2RX4 P2RX7 SYNJ1 CADPS BTK ABCB11 EIF2AK3 RIC1 | 1.71e-04 | 1221 | 127 | 19 | GO:0046903 |
| GeneOntologyBiologicalProcess | regulation of prostaglandin secretion | 1.74e-04 | 18 | 127 | 3 | GO:0032306 | |
| GeneOntologyBiologicalProcess | regulation of system process | ADCY10 DOCK4 CACNA1C FLNA WNK1 SHANK3 GTF2IRD2B P2RX1 P2RX4 GTF2IRD2 MMP2 CTTN EIF2AK3 RBFOX2 | 1.74e-04 | 734 | 127 | 14 | GO:0044057 |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.75e-04 | 133 | 127 | 6 | GO:0006939 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | ADCY10 CACNA1C FLNA NTRK2 NTRK3 SHANK3 P2RX1 P2RX3 P2RX4 P2RX7 P2RX6 RBFOX2 | 1.77e-04 | 559 | 127 | 12 | GO:0042391 |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | ADCY10 CACNA1C FLNA CD2AP PFKM MALRD1 P2RX7 CCT5 TENM1 HCLS1 | 1.99e-04 | 403 | 127 | 10 | GO:1904951 |
| GeneOntologyBiologicalProcess | response to wounding | FLNA DDR1 VWF MORN4 MYLK NTRK3 CD2AP METAP1 P2RX1 P2RX4 ENTPD2 MMP2 KLKB1 | 2.17e-04 | 659 | 127 | 13 | GO:0009611 |
| GeneOntologyBiologicalProcess | response to glial cell derived neurotrophic factor | 2.24e-04 | 4 | 127 | 2 | GO:1990790 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway | 2.24e-04 | 4 | 127 | 2 | GO:1903378 | |
| GeneOntologyBiologicalProcess | regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway | 2.41e-04 | 20 | 127 | 3 | GO:1903376 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | FLNA CD2AP PFN2 CLIP1 SHANK3 DRG1 SPTBN5 P2RX7 TENM1 CTTN TACSTD2 HCLS1 | 2.45e-04 | 579 | 127 | 12 | GO:0051493 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 2.46e-04 | 266 | 127 | 8 | GO:0019722 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | FLNA RAP1GAP MYLK WNT1 CD2AP PFN2 CFAP298 P2RX4 P2RX7 ARL13B TENM1 CTTN TACSTD2 | 2.55e-04 | 670 | 127 | 13 | GO:0120031 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | ADCY10 FLNA DDR1 RAP1GAP CAMK1D WNT1 NTRK2 NTRK3 COLEC10 PFN2 WNK1 CLIP1 SHANK3 DRG1 P2RX7 SYNJ1 CCT5 BTK TENM1 CTTN | 2.55e-04 | 1366 | 127 | 20 | GO:0051130 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport into cytosol | 2.80e-04 | 21 | 127 | 3 | GO:0010524 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 2.80e-04 | 21 | 127 | 3 | GO:0071318 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | 2.82e-04 | 205 | 127 | 7 | GO:0051495 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | ADCY10 CACNA1C FLNA CD2AP PFKM MALRD1 P2RX7 CCT5 TENM1 PRKCH EIF2AK3 HCLS1 | 2.95e-04 | 591 | 127 | 12 | GO:1903829 |
| GeneOntologyBiologicalProcess | response to cold | 2.95e-04 | 52 | 127 | 4 | GO:0009409 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 3.01e-04 | 147 | 127 | 6 | GO:0099565 | |
| GeneOntologyBiologicalProcess | cell projection assembly | FLNA RAP1GAP MYLK WNT1 CD2AP PFN2 CFAP298 P2RX4 P2RX7 ARL13B TENM1 CTTN TACSTD2 | 3.15e-04 | 685 | 127 | 13 | GO:0030031 |
| GeneOntologyBiologicalProcess | neuron intrinsic apoptotic signaling pathway in response to oxidative stress | 3.22e-04 | 22 | 127 | 3 | GO:0036480 | |
| GeneOntologyBiologicalProcess | prostaglandin secretion | 3.22e-04 | 22 | 127 | 3 | GO:0032310 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | ADCY10 DDR1 WNT1 NTRK2 NTRK3 HIPK2 PFN2 GRK1 MST1R TNFSF11 P2RX7 TENM1 HSPA2 HCLS1 | 3.24e-04 | 780 | 127 | 14 | GO:0042327 |
| GeneOntologyBiologicalProcess | regulation of vasoconstriction | 3.51e-04 | 98 | 127 | 5 | GO:0019229 | |
| GeneOntologyBiologicalProcess | chemotaxis | SEMA6C DOCK4 CAMK1D DUSP1 NTRK3 COLEC10 WNK1 TNFSF11 P2RX4 MMP2 CTTN | 3.58e-04 | 517 | 127 | 11 | GO:0006935 |
| GeneOntologyBiologicalProcess | cell migration in hindbrain | 3.69e-04 | 23 | 127 | 3 | GO:0021535 | |
| GeneOntologyBiologicalProcess | ATP transport | 3.69e-04 | 23 | 127 | 3 | GO:0015867 | |
| GeneOntologyBiologicalProcess | taxis | SEMA6C DOCK4 CAMK1D DUSP1 NTRK3 COLEC10 WNK1 TNFSF11 P2RX4 MMP2 CTTN | 3.70e-04 | 519 | 127 | 11 | GO:0042330 |
| GeneOntologyBiologicalProcess | formation of radial glial scaffolds | 3.72e-04 | 5 | 127 | 2 | GO:0021943 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | ADCY10 FLNA DDR1 VWF NTRK2 NTRK3 HIPK2 IFI35 MST1R TNFSF11 P2RX3 P2RX4 P2RX7 BTK TENM1 MMP2 EIF2AK2 EIF2AK3 HCLS1 | 3.74e-04 | 1299 | 127 | 19 | GO:1902533 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 3.86e-04 | 438 | 127 | 10 | GO:1902903 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 3.98e-04 | 217 | 127 | 7 | GO:0051897 | |
| GeneOntologyBiologicalProcess | positive regulation of icosanoid secretion | 4.20e-04 | 24 | 127 | 3 | GO:0032305 | |
| GeneOntologyBiologicalProcess | regulation of secretion | CACNA1C NTRK2 CD2AP PFKM PFN2 WNK1 TNFSF11 MALRD1 P2RX1 P2RX4 P2RX7 CADPS ABCB11 RIC1 | 4.22e-04 | 801 | 127 | 14 | GO:0051046 |
| GeneOntologyBiologicalProcess | positive regulation of protein polymerization | 4.23e-04 | 102 | 127 | 5 | GO:0032273 | |
| GeneOntologyBiologicalProcess | response to axon injury | 4.83e-04 | 105 | 127 | 5 | GO:0048678 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 5.35e-04 | 228 | 127 | 7 | GO:0046777 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 5.45e-04 | 61 | 127 | 4 | GO:0003254 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 5.48e-04 | 300 | 127 | 8 | GO:0110053 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 5.78e-04 | 231 | 127 | 7 | GO:0032271 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | FLNA PCGF2 CAMK1D DOCK8 WNT1 NTRK2 DUSP1 CD2AP HIPK2 GRK1 SMG9 PRKCH CTTN EIF2AK2 EIF2AK3 HCLS1 RBFOX2 | 5.87e-04 | 1133 | 127 | 17 | GO:0043066 |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport into cytosol | 5.98e-04 | 27 | 127 | 3 | GO:0010522 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial depolarization | 5.98e-04 | 27 | 127 | 3 | GO:0051900 | |
| GeneOntologyBiologicalProcess | positive regulation of organic acid transport | 6.17e-04 | 63 | 127 | 4 | GO:0032892 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 6.17e-04 | 63 | 127 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 6.29e-04 | 384 | 127 | 9 | GO:0032956 | |
| GeneOntologyBiologicalProcess | positive regulation of response to external stimulus | FLNA CAMK1D NTRK3 COLEC10 WNK1 IFI35 TXK TNFSF11 P2RX4 BTK CTTN PSPC1 EIF2AK2 | 6.35e-04 | 738 | 127 | 13 | GO:0032103 |
| GeneOntologyBiologicalProcess | regulation of translation in response to stress | 6.67e-04 | 28 | 127 | 3 | GO:0043555 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to nucleus | 7.03e-04 | 114 | 127 | 5 | GO:1900182 | |
| GeneOntologyBiologicalProcess | positive regulation of fatty acid transport | 7.41e-04 | 29 | 127 | 3 | GO:2000193 | |
| GeneOntologyBiologicalProcess | regulation of icosanoid secretion | 7.41e-04 | 29 | 127 | 3 | GO:0032303 | |
| GeneOntologyBiologicalProcess | negative regulation of ruffle assembly | 7.74e-04 | 7 | 127 | 2 | GO:1900028 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 7.85e-04 | 317 | 127 | 8 | GO:0090257 | |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | 8.18e-04 | 319 | 127 | 8 | GO:0051222 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | FLNA PCGF2 CAMK1D DOCK8 WNT1 NTRK2 DUSP1 CD2AP HIPK2 GRK1 SMG9 PRKCH CTTN EIF2AK2 EIF2AK3 HCLS1 RBFOX2 | 8.48e-04 | 1171 | 127 | 17 | GO:0043069 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | 8.78e-04 | 248 | 127 | 7 | GO:0120032 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 8.78e-04 | 180 | 127 | 6 | GO:0060078 | |
| GeneOntologyBiologicalProcess | vasoconstriction | 9.19e-04 | 121 | 127 | 5 | GO:0042310 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 9.19e-04 | 121 | 127 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 9.41e-04 | 326 | 127 | 8 | GO:1903522 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | 9.54e-04 | 582 | 127 | 11 | GO:0044089 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 9.75e-04 | 494 | 127 | 10 | GO:0031346 | |
| GeneOntologyBiologicalProcess | regulation of ruffle assembly | 9.92e-04 | 32 | 127 | 3 | GO:1900027 | |
| GeneOntologyBiologicalProcess | eiF2alpha phosphorylation in response to endoplasmic reticulum stress | 1.03e-03 | 8 | 127 | 2 | GO:0036492 | |
| GeneOntologyBiologicalProcess | regulation of translation initiation in response to endoplasmic reticulum stress | 1.03e-03 | 8 | 127 | 2 | GO:0036491 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FLNA MYL1 CDC42BPA MYLK CD2AP CDC42BPB SLC2A1 SPTBN5 MST1R SH3PXD2A MYL6B CTTN HCLS1 | 5.86e-05 | 576 | 129 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | translation release factor complex | 1.13e-04 | 3 | 129 | 2 | GO:0018444 | |
| GeneOntologyCellularComponent | terminal bouton | 3.23e-04 | 96 | 129 | 5 | GO:0043195 | |
| GeneOntologyCellularComponent | photoreceptor disc membrane | 5.38e-04 | 26 | 129 | 3 | GO:0097381 | |
| GeneOntologyCellularComponent | dendrite | ADCY10 CACNA1C FLNA RAP1GAP NTRK2 CD2AP SHANK3 SLC12A5 CNNM1 P2RX3 P2RX4 SACS P2RX6 CTTN | 8.51e-04 | 858 | 129 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ADCY10 CACNA1C FLNA RAP1GAP NTRK2 CD2AP SHANK3 SLC12A5 CNNM1 P2RX3 P2RX4 SACS P2RX6 CTTN | 8.71e-04 | 860 | 129 | 14 | GO:0097447 |
| HumanPheno | Mitral valve prolapse | 7.05e-06 | 123 | 57 | 9 | HP:0001634 | |
| HumanPheno | Abnormal mitral valve morphology | 2.84e-05 | 146 | 57 | 9 | HP:0031477 | |
| MousePheno | abnormal pain threshold | SEMA6C CACNA1C RARS1 SHANK3 PRX SLC12A5 P2RX3 CLCN6 P2RX7 P2RX6 | 3.20e-05 | 267 | 105 | 10 | MP:0001970 |
| MousePheno | abnormal thermal nociception | 3.82e-05 | 168 | 105 | 8 | MP:0002733 | |
| MousePheno | hypoalgesia | 4.15e-05 | 170 | 105 | 8 | MP:0003043 | |
| Domain | P2X_receptor | 3.02e-10 | 7 | 129 | 5 | PF00864 | |
| Domain | P2X_purnocptor | 3.02e-10 | 7 | 129 | 5 | IPR001429 | |
| Domain | - | 3.02e-10 | 7 | 129 | 5 | 2.60.490.10 | |
| Domain | P2X_RECEPTOR | 3.02e-10 | 7 | 129 | 5 | PS01212 | |
| Domain | P2X_extracellular_dom | 3.02e-10 | 7 | 129 | 5 | IPR027309 | |
| Domain | PROTEIN_KINASE_ATP | CDC42BPG DDR1 CDC42BPA CAMK1D MYLK GRK7 NTRK2 NTRK3 HIPK2 WNK1 CDC42BPB GRK1 TXK MST1R BTK PRKCH EIF2AK2 EIF2AK3 | 2.75e-09 | 459 | 129 | 18 | PS00107 |
| Domain | Prot_kinase_dom | CDC42BPG DDR1 CDC42BPA CAMK1D MYLK GRK7 NTRK2 NTRK3 HIPK2 WNK1 CDC42BPB GRK1 TXK MST1R BTK PRKCH EIF2AK2 EIF2AK3 | 7.40e-09 | 489 | 129 | 18 | IPR000719 |
| Domain | Protein_kinase_ATP_BS | CDC42BPG CDC42BPA CAMK1D MYLK GRK7 NTRK2 NTRK3 HIPK2 CDC42BPB GRK1 TXK MST1R BTK PRKCH EIF2AK2 EIF2AK3 | 7.99e-09 | 379 | 129 | 16 | IPR017441 |
| Domain | PROTEIN_KINASE_DOM | CDC42BPG DDR1 CDC42BPA CAMK1D MYLK GRK7 NTRK2 NTRK3 HIPK2 WNK1 CDC42BPB GRK1 TXK MST1R BTK PRKCH EIF2AK2 EIF2AK3 | 8.39e-09 | 493 | 129 | 18 | PS50011 |
| Domain | Kinase-like_dom | CDC42BPG DDR1 CDC42BPA CAMK1D MYLK GRK7 NTRK2 NTRK3 HIPK2 WNK1 CDC42BPB GRK1 TXK MST1R BTK PRKCH EIF2AK2 EIF2AK3 | 3.59e-08 | 542 | 129 | 18 | IPR011009 |
| Domain | Myotonic_dystrophy_kinase_coil | 1.28e-06 | 4 | 129 | 3 | IPR014930 | |
| Domain | Myotonic_dystrophy_kinase_coil | 1.28e-06 | 4 | 129 | 3 | PD011252 | |
| Domain | DMPK_coil | 1.28e-06 | 4 | 129 | 3 | PF08826 | |
| Domain | AGC-kinase_C | 2.36e-06 | 56 | 129 | 6 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.36e-06 | 56 | 129 | 6 | PS51285 | |
| Domain | S_TK_X | 2.36e-06 | 56 | 129 | 6 | SM00133 | |
| Domain | Ser/Thr_kinase_AS | CDC42BPG CDC42BPA CAMK1D MYLK GRK7 HIPK2 WNK1 CDC42BPB GRK1 PRKCH EIF2AK2 EIF2AK3 | 6.97e-06 | 357 | 129 | 12 | IPR008271 |
| Domain | S_TKc | CDC42BPG CDC42BPA CAMK1D MYLK GRK7 HIPK2 WNK1 CDC42BPB GRK1 PRKCH EIF2AK2 EIF2AK3 | 7.37e-06 | 359 | 129 | 12 | SM00220 |
| Domain | PROTEIN_KINASE_ST | CDC42BPG CDC42BPA CAMK1D MYLK GRK7 HIPK2 WNK1 CDC42BPB GRK1 PRKCH EIF2AK2 EIF2AK3 | 8.02e-06 | 362 | 129 | 12 | PS00108 |
| Domain | Pkinase | CDC42BPG CDC42BPA CAMK1D MYLK GRK7 HIPK2 WNK1 CDC42BPB GRK1 PRKCH EIF2AK2 EIF2AK3 | 1.34e-05 | 381 | 129 | 12 | PF00069 |
| Domain | Tyr_kinase_cat_dom | 3.29e-05 | 88 | 129 | 6 | IPR020635 | |
| Domain | TyrKc | 3.29e-05 | 88 | 129 | 6 | SM00219 | |
| Domain | CORTACTIN | 4.73e-05 | 2 | 129 | 2 | PS51090 | |
| Domain | CXorf40 | 4.73e-05 | 2 | 129 | 2 | IPR033615 | |
| Domain | KELK | 4.73e-05 | 2 | 129 | 2 | IPR031597 | |
| Domain | KELK | 4.73e-05 | 2 | 129 | 2 | PF15796 | |
| Domain | HS1_rep | 4.73e-05 | 2 | 129 | 2 | PF02218 | |
| Domain | Hs1_Cortactin | 4.73e-05 | 2 | 129 | 2 | IPR003134 | |
| Domain | Tyr_kinase_rcpt_2_CS | 5.10e-05 | 11 | 129 | 3 | IPR002011 | |
| Domain | PROTEIN_KINASE_TYR | 5.71e-05 | 97 | 129 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.71e-05 | 97 | 129 | 6 | IPR008266 | |
| Domain | RECEPTOR_TYR_KIN_II | 6.77e-05 | 12 | 129 | 3 | PS00239 | |
| Domain | CNH | 1.11e-04 | 14 | 129 | 3 | SM00036 | |
| Domain | Pkinase_C | 1.20e-04 | 37 | 129 | 4 | IPR017892 | |
| Domain | SH3 | 1.29e-04 | 216 | 129 | 8 | SM00326 | |
| Domain | SH3 | 1.29e-04 | 216 | 129 | 8 | PS50002 | |
| Domain | CNH | 1.38e-04 | 15 | 129 | 3 | PF00780 | |
| Domain | CNH | 1.38e-04 | 15 | 129 | 3 | PS50219 | |
| Domain | CNH_dom | 1.38e-04 | 15 | 129 | 3 | IPR001180 | |
| Domain | ASCH_domain | 1.41e-04 | 3 | 129 | 2 | IPR007374 | |
| Domain | Fox-1_C | 1.41e-04 | 3 | 129 | 2 | PF12414 | |
| Domain | ASCH | 1.41e-04 | 3 | 129 | 2 | SM01022 | |
| Domain | Fox-1_C_dom | 1.41e-04 | 3 | 129 | 2 | IPR025670 | |
| Domain | TPKR_C2 | 1.41e-04 | 3 | 129 | 2 | PF16920 | |
| Domain | Tyr_kinase_NGF_rcpt | 1.41e-04 | 3 | 129 | 2 | IPR020777 | |
| Domain | NTRK_C2 | 1.41e-04 | 3 | 129 | 2 | IPR031635 | |
| Domain | RNA-bd_Fox-1 | 1.41e-04 | 3 | 129 | 2 | IPR017325 | |
| Domain | SH3_domain | 1.47e-04 | 220 | 129 | 8 | IPR001452 | |
| Domain | Pkinase_C | 1.98e-04 | 42 | 129 | 4 | PF00433 | |
| Domain | Pkinase_Tyr | 2.75e-04 | 129 | 129 | 6 | PF07714 | |
| Domain | - | 2.81e-04 | 4 | 129 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 2.81e-04 | 4 | 129 | 2 | PS51139 | |
| Domain | GTF2I | 2.81e-04 | 4 | 129 | 2 | PF02946 | |
| Domain | GTF2I | 2.81e-04 | 4 | 129 | 2 | IPR004212 | |
| Domain | VWC_out | 2.88e-04 | 19 | 129 | 3 | SM00215 | |
| Domain | CRIB | 3.37e-04 | 20 | 129 | 3 | PS50108 | |
| Domain | CRIB_dom | 3.91e-04 | 21 | 129 | 3 | IPR000095 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.94e-04 | 138 | 129 | 6 | IPR001245 | |
| Domain | C1_1 | 6.46e-04 | 57 | 129 | 4 | PF00130 | |
| Domain | GPCR_kinase | 9.72e-04 | 7 | 129 | 2 | IPR000239 | |
| Domain | SH3_1 | 9.78e-04 | 164 | 129 | 6 | PF00018 | |
| Domain | ZF_DAG_PE_1 | 1.00e-03 | 64 | 129 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.00e-03 | 64 | 129 | 4 | PS50081 | |
| Domain | C1 | 1.06e-03 | 65 | 129 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 1.12e-03 | 66 | 129 | 4 | IPR002219 | |
| Domain | Transl_elong_EFTu/EF1A_C | 1.29e-03 | 8 | 129 | 2 | IPR004160 | |
| Domain | GTP_EFTU_D3 | 1.29e-03 | 8 | 129 | 2 | PF03143 | |
| Domain | G_TR_CS | 1.65e-03 | 9 | 129 | 2 | IPR031157 | |
| Domain | VWFC_1 | 1.95e-03 | 36 | 129 | 3 | PS01208 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 2.05e-03 | 10 | 129 | 2 | IPR009001 | |
| Domain | VWFC_2 | 2.28e-03 | 38 | 129 | 3 | PS50184 | |
| Domain | VWC | 2.28e-03 | 38 | 129 | 3 | SM00214 | |
| Domain | DHR-1_domain | 2.50e-03 | 11 | 129 | 2 | IPR027007 | |
| Domain | DHR_2 | 2.50e-03 | 11 | 129 | 2 | PS51651 | |
| Domain | DHR_1 | 2.50e-03 | 11 | 129 | 2 | PS51650 | |
| Domain | DHR-2 | 2.50e-03 | 11 | 129 | 2 | PF06920 | |
| Domain | DOCK | 2.50e-03 | 11 | 129 | 2 | IPR026791 | |
| Domain | DOCK_C | 2.50e-03 | 11 | 129 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 2.50e-03 | 11 | 129 | 2 | PF14429 | |
| Domain | DHR-2 | 2.50e-03 | 11 | 129 | 2 | IPR027357 | |
| Domain | C8 | 2.99e-03 | 12 | 129 | 2 | PF08742 | |
| Domain | TIL | 2.99e-03 | 12 | 129 | 2 | PF01826 | |
| Domain | VWF_dom | 3.04e-03 | 42 | 129 | 3 | IPR001007 | |
| Domain | G_TR_1 | 3.51e-03 | 13 | 129 | 2 | PS00301 | |
| Domain | Unchr_dom_Cys-rich | 3.51e-03 | 13 | 129 | 2 | IPR014853 | |
| Domain | C8 | 3.51e-03 | 13 | 129 | 2 | SM00832 | |
| Domain | TIL_dom | 4.08e-03 | 14 | 129 | 2 | IPR002919 | |
| Domain | GROEL-like_equatorial | 4.08e-03 | 14 | 129 | 2 | IPR027413 | |
| Domain | - | 4.08e-03 | 14 | 129 | 2 | 1.10.560.10 | |
| Domain | GroEL-like_apical_dom | 4.69e-03 | 15 | 129 | 2 | IPR027409 | |
| Domain | Cpn60/TCP-1 | 4.69e-03 | 15 | 129 | 2 | IPR002423 | |
| Domain | Cpn60_TCP1 | 4.69e-03 | 15 | 129 | 2 | PF00118 | |
| Domain | - | 4.69e-03 | 15 | 129 | 2 | 3.50.7.10 | |
| Domain | PH | 5.18e-03 | 229 | 129 | 6 | PF00169 | |
| Domain | CBS | 5.33e-03 | 16 | 129 | 2 | SM00116 | |
| Domain | VWF_type-D | 5.33e-03 | 16 | 129 | 2 | IPR001846 | |
| Domain | VWFD | 5.33e-03 | 16 | 129 | 2 | PS51233 | |
| Domain | VWD | 5.33e-03 | 16 | 129 | 2 | SM00216 | |
| Domain | PBD | 5.33e-03 | 16 | 129 | 2 | SM00285 | |
| Domain | VWD | 5.33e-03 | 16 | 129 | 2 | PF00094 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL | 1.30e-08 | 12 | 101 | 5 | M47953 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.10e-08 | 13 | 101 | 5 | MM14553 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 7.01e-08 | 16 | 101 | 5 | M26945 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.22e-06 | 27 | 101 | 5 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.47e-06 | 28 | 101 | 5 | M924 | |
| Pathway | WP_PURINERGIC_SIGNALING | 3.46e-06 | 33 | 101 | 5 | M39855 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 2.11e-04 | 76 | 101 | 5 | MM15051 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.88e-04 | 178 | 101 | 7 | M2890 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 3.76e-04 | 86 | 101 | 5 | M916 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 4.32e-04 | 21 | 101 | 3 | M27494 | |
| Pubmed | Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. | 1.41e-11 | 7 | 130 | 5 | 33125712 | |
| Pubmed | Membrane compartments and purinergic signalling: occurrence and function of P2X receptors in lung. | 1.41e-11 | 7 | 130 | 5 | 19076210 | |
| Pubmed | 1.41e-11 | 7 | 130 | 5 | 18657557 | ||
| Pubmed | Go it alone no more--P2X7 joins the society of heteromeric ATP-gated receptor channels. | 1.41e-11 | 7 | 130 | 5 | 17895406 | |
| Pubmed | PCGF2 CDC42BPA CAMK1D MYLK MTHFD2 GRK7 USP24 HIPK2 WNK1 CDC42BPB GSPT1 GRK1 METAP1 ENTPD2 PRKCH PPIL2 MMP2 PSPC1 | 2.91e-10 | 730 | 130 | 18 | 34857952 | |
| Pubmed | DOCK4 FLNA CDC42BPA MORN4 RARS1 KIAA0513 ACADVL NTRK2 USP24 PFN2 CDC42BPB SHANK3 GSPT2 SYNJ1 CCT5 HNRNPUL2 CADPS TENM1 CTTN HSPA2 FAM177A1 | 1.63e-09 | 1139 | 130 | 21 | 36417873 | |
| Pubmed | 2.78e-09 | 6 | 130 | 4 | 12270951 | ||
| Pubmed | ACADVL PFN2 WNK1 CDC42BPB SLC2A1 SYNJ1 CCT5 SACS SH3PXD2A STEEP1 | 1.75e-08 | 230 | 130 | 10 | 35449600 | |
| Pubmed | Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. | 5.10e-08 | 3 | 130 | 3 | 19552691 | |
| Pubmed | Ambulatory blood pressure is associated with polymorphic variation in P2X receptor genes. | 5.10e-08 | 3 | 130 | 3 | 18852390 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 32805257 | ||
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 20699225 | ||
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 15087444 | ||
| Pubmed | Subtype-specific control of P2X receptor channel signaling by ATP and Mg2+. | 2.04e-07 | 4 | 130 | 3 | 23959888 | |
| Pubmed | FLNA EXOSC9 VWF CDC42BPA DUSP1 HIPK2 ITPRID2 WNK1 CDC42BPB BTK PRKCH RBFOX2 | 3.15e-07 | 486 | 130 | 12 | 20936779 | |
| Pubmed | FLNA RAP1GAP VWF DOCK8 PFKM PFN2 CDC42BPB SHANK3 SLC2A1 SLC12A5 P2RX3 CLCN6 SYNJ1 CCT5 SACS HNRNPUL2 CADPS CTTN PSPC1 HSPA2 | 3.79e-07 | 1431 | 130 | 20 | 37142655 | |
| Pubmed | CACNA1C FLNA MYLK PCDHGB6 ACADVL PFKM PRX GSPT1 GTF2IRD2B GSPT2 SACS SH3PXD2A TCHHL1 ENTPD2 GTF2IRD2 TENM1 CTTN PSPC1 HSPA2 HCLS1 | 4.28e-07 | 1442 | 130 | 20 | 35575683 | |
| Pubmed | Developmental control of CaV1.2 L-type calcium channel splicing by Fox proteins. | 5.08e-07 | 5 | 130 | 3 | 19564422 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 28428949 | ||
| Pubmed | 7.24e-07 | 83 | 130 | 6 | 11114734 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C FLNA FRAS1 LZTR1 CDC42BPA KIAA0513 MYOM3 MED14 WNK1 CDC42BPB SLC2A1 FAM83H MST1R SYNJ1 ENTPD2 ZFYVE26 RIC1 | 8.47e-07 | 1105 | 130 | 17 | 35748872 |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 9.81e-07 | 139 | 130 | 7 | 16985003 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | DDR1 HECTD3 GRK7 NTRK2 NTRK3 BTK GTF2IRD2 PRKCH EIF2AK2 HERC4 | 1.48e-06 | 372 | 130 | 10 | 22939624 |
| Pubmed | 1.77e-06 | 7 | 130 | 3 | 29162624 | ||
| Pubmed | Functional genomics identifies therapeutic targets for MYC-driven cancer. | 2.58e-06 | 103 | 130 | 6 | 22623531 | |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 6.10e-06 | 183 | 130 | 7 | 31932471 | |
| Pubmed | 6.18e-06 | 32 | 130 | 4 | 26758845 | ||
| Pubmed | 1.10e-05 | 12 | 130 | 3 | 12672817 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 1.12e-05 | 37 | 130 | 4 | 27565344 | |
| Pubmed | SLC25A24 EXOSC9 CDC42BPA RARS1 CD2AP MED14 ITPRID2 CDC42BPB SLC2A1 DRG1 METAP1 CCT5 SLC4A1AP METTL18 PSPC1 TACSTD2 EIF2AK2 TBL2 | 1.22e-05 | 1497 | 130 | 18 | 31527615 | |
| Pubmed | 1.28e-05 | 136 | 130 | 6 | 22304920 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FLNA MYL1 RARS1 MTHFD2 ITPRID2 GSPT2 CCT5 HNRNPUL2 MYL6B STEEP1 PPIL2 CTTN HSPA2 EIF2AK2 | 1.35e-05 | 949 | 130 | 14 | 36574265 |
| Pubmed | Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder. | 1.39e-05 | 2 | 130 | 2 | 28753255 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 27312548 | ||
| Pubmed | Abnormal development of pacinian corpuscles in double trkB;trkC knockout mice. | 1.39e-05 | 2 | 130 | 2 | 17101216 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 35254644 | ||
| Pubmed | Mechanisms of activation and repression by the alternative splicing factors RBFOX1/2. | 1.39e-05 | 2 | 130 | 2 | 22184459 | |
| Pubmed | Repression of prespliceosome complex formation at two distinct steps by Fox-1/Fox-2 proteins. | 1.39e-05 | 2 | 130 | 2 | 18573872 | |
| Pubmed | Molecular characterization and pharmacological properties of the human P2X3 purinoceptor. | 1.39e-05 | 2 | 130 | 2 | 9221902 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 9195161 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15987998 | ||
| Pubmed | Coexpression of glucose transporter 1 and matrix metalloproteinase-2 in human cancers. | 1.39e-05 | 2 | 130 | 2 | 12122099 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 22451435 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23303206 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 21562748 | ||
| Pubmed | Cloning and chromosomal localization of human Cdc42-binding protein kinase beta. | 1.39e-05 | 2 | 130 | 2 | 10198171 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 9016352 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28949795 | ||
| Pubmed | Rbfox-Splicing Factors Maintain Skeletal Muscle Mass by Regulating Calpain3 and Proteostasis. | 1.39e-05 | 2 | 130 | 2 | 29972780 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24845338 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 22899855 | ||
| Pubmed | Functional interactions between P2X4 and P2X7 receptors from mouse salivary epithelia. | 1.39e-05 | 2 | 130 | 2 | 19403602 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 29176664 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23090967 | ||
| Pubmed | The endoplasmic reticulum-localized protein TBL2 interacts with the 60S ribosomal subunit. | 1.39e-05 | 2 | 130 | 2 | 25976671 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17934511 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 35119925 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15824060 | ||
| Pubmed | Characterization and mechanism of P2X receptor-mediated increase in cardiac myocyte contractility. | 1.39e-05 | 2 | 130 | 2 | 17873021 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 27581227 | ||
| Pubmed | TrkB but not trkC receptors are necessary for postnatal maintenance of hippocampal spines. | 1.39e-05 | 2 | 130 | 2 | 17442456 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 18263588 | ||
| Pubmed | Involvement of P2X4 receptor in P2X7 receptor-dependent cell death of mouse macrophages. | 1.39e-05 | 2 | 130 | 2 | 22349510 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15056655 | ||
| Pubmed | P2X currents in peritoneal macrophages of wild type and P2X4 -/- mice. | 1.39e-05 | 2 | 130 | 2 | 17825926 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 35536742 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 22183412 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 14622193 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 25938443 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 9421165 | ||
| Pubmed | The combined effects of trkB and trkC mutations on the innervation of the inner ear. | 1.39e-05 | 2 | 130 | 2 | 9881298 | |
| Pubmed | Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms. | 1.39e-05 | 2 | 130 | 2 | 32315394 | |
| Pubmed | Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. | 1.39e-05 | 2 | 130 | 2 | 18794351 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 31401785 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 22988022 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15726425 | ||
| Pubmed | Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways. | 1.39e-05 | 2 | 130 | 2 | 28709407 | |
| Pubmed | Purinergic receptors P2RX4 and P2RX7 in familial multiple sclerosis. | 1.39e-05 | 2 | 130 | 2 | 28326637 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12610133 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15946941 | ||
| Pubmed | Atypical P2X receptor pharmacology in two human osteoblast-like cell lines. | 1.39e-05 | 2 | 130 | 2 | 19226284 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 38740782 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 26126716 | ||
| Pubmed | Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation. | 1.39e-05 | 2 | 130 | 2 | 17675190 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 20110693 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23332094 | ||
| Pubmed | Novel interaction of cortactin with endothelial cell myosin light chain kinase. | 1.39e-05 | 2 | 130 | 2 | 12408982 | |
| Pubmed | A common cortactin gene variation confers differential susceptibility to severe asthma. | 1.39e-05 | 2 | 130 | 2 | 18521921 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19304656 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23428419 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28238652 | ||
| Pubmed | Conditional deletion of TrkC does not modify limbic epileptogenesis. | 1.39e-05 | 2 | 130 | 2 | 22980123 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15710041 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17785580 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 25609712 | ||
| Pubmed | Distinct requirements for TrkB and TrkC signaling in target innervation by sensory neurons. | 1.39e-05 | 2 | 130 | 2 | 11877382 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 18293376 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 38953020 | ||
| Pubmed | Rbfox proteins regulate alternative splicing of neuronal sodium channel SCN8A. | 1.39e-05 | 2 | 130 | 2 | 22044765 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17785458 | ||
| Interaction | MYO6 interactions | FLNA DOCK8 NTRK2 NTRK3 CD2AP USP25 PFN2 SLC2A1 SYNJ1 MYL6B ARL13B CTTN | 7.06e-06 | 398 | 125 | 12 | int:MYO6 |
| Interaction | GRB2 interactions | DOCK4 FLNA RARS1 NTRK2 NTRK3 CD2AP SHANK3 DRG1 TXK MST1R SYNJ1 CCT5 SH3PXD2A BTK CTTN PSPC1 HCLS1 | 1.01e-05 | 806 | 125 | 17 | int:GRB2 |
| Cytoband | 12p13.3 | 8.52e-05 | 30 | 130 | 3 | 12p13.3 | |
| GeneFamily | Purinergic receptors P2X | 1.81e-11 | 7 | 72 | 5 | 214 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.90e-05 | 40 | 72 | 4 | 321 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.55e-04 | 161 | 72 | 5 | 593 | |
| GeneFamily | Myosin light chains|EF-hand domain containing | 1.38e-03 | 14 | 72 | 2 | 657 | |
| GeneFamily | Chaperonins | 1.59e-03 | 15 | 72 | 2 | 587 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | DOCK4 RAP1GAP PCGF2 CDC42BPA ACADVL PFN2 CLIP1 CDC42BPB GSPT1 SACS MMP2 CTTN PSPC1 TBL2 HCLS1 RBFOX2 | 1.98e-06 | 790 | 130 | 16 | M12490 |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN | 7.06e-06 | 199 | 130 | 8 | M3622 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.27e-05 | 155 | 130 | 7 | M39246 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP | 3.40e-05 | 74 | 130 | 5 | M515 | |
| Coexpression | GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN | 6.29e-05 | 199 | 130 | 7 | M3313 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN | 6.29e-05 | 199 | 130 | 7 | M8487 | |
| Coexpression | HALLMARK_IL2_STAT5_SIGNALING | 6.29e-05 | 199 | 130 | 7 | M5947 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP | 6.49e-05 | 200 | 130 | 7 | M7037 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN | 6.49e-05 | 200 | 130 | 7 | M3635 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.66e-08 | 162 | 130 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.75e-08 | 186 | 130 | 8 | c7885fd6dc7dc8fffc96f0112c51a365cf8a8f80 | |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 9.51e-08 | 191 | 130 | 8 | 2da83c493e60ad0278848957645277d76737a188 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-07 | 151 | 130 | 7 | 523dcd243c285a6b74830a93c82cca8784edd658 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-07 | 151 | 130 | 7 | f3406094ce79cc80398b82d58ca6fd87a96e68d4 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 7.22e-07 | 171 | 130 | 7 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-06 | 187 | 130 | 7 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.36e-06 | 188 | 130 | 7 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.57e-06 | 192 | 130 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.62e-06 | 193 | 130 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.68e-06 | 194 | 130 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 195 | 130 | 7 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.06e-06 | 200 | 130 | 7 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.36e-06 | 159 | 130 | 6 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.36e-06 | 159 | 130 | 6 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 9.10e-06 | 165 | 130 | 6 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.10e-06 | 165 | 130 | 6 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.42e-06 | 166 | 130 | 6 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.42e-06 | 166 | 130 | 6 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 173 | 130 | 6 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 173 | 130 | 6 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-05 | 174 | 130 | 6 | eb8012823b08729b462d1e5212f4873bb6b4eb1e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-05 | 174 | 130 | 6 | 32fdeeebeeeca657eac6329caad4c28ca54e4d1c | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 175 | 130 | 6 | 294a70786260c9a2b1ba16c88819d786698609e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 175 | 130 | 6 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 175 | 130 | 6 | 798f33bd340261c048b7b45c842b2ccd1ea1fb60 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 175 | 130 | 6 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 177 | 130 | 6 | 9e65b39fd797b6ce204b6480415810d1923acee5 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 1.45e-05 | 179 | 130 | 6 | 4e0cf069bc47328eda753a4edc7e89b8915d52bb | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.45e-05 | 179 | 130 | 6 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.49e-05 | 180 | 130 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 108 | 130 | 5 | fcc26843a8788f0fe3cec14dcae083830da80b8f | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 108 | 130 | 5 | c1c68e328fdf5216f23845b4de9a3b1bbe61b11c | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-05 | 183 | 130 | 6 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-05 | 183 | 130 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 183 | 130 | 6 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 183 | 130 | 6 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-05 | 186 | 130 | 6 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | (5)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.80e-05 | 186 | 130 | 6 | acbca8cc048d87faf859b3e77bdb38d0a3dad71c | |
| ToppCell | (5)_Pericytes-(50)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.80e-05 | 186 | 130 | 6 | 67b59defdd1ed3608229cc5e2a3b480d92312afa | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.91e-05 | 188 | 130 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-05 | 188 | 130 | 6 | 72a1ee136d77c77e44793a512f60b5f7815a073a | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-05 | 188 | 130 | 6 | ecbba19eebba21b986caa99de78ea4245fde3600 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 189 | 130 | 6 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 189 | 130 | 6 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-05 | 190 | 130 | 6 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-05 | 190 | 130 | 6 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 192 | 130 | 6 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 192 | 130 | 6 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.15e-05 | 192 | 130 | 6 | 5417f024fcc89eaeab33f4a2c6421d1cfabd681b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 192 | 130 | 6 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 2.15e-05 | 192 | 130 | 6 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-05 | 192 | 130 | 6 | 5995bae840c0b3f420288f557634d0ae9a12a6ae | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.21e-05 | 193 | 130 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.21e-05 | 193 | 130 | 6 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.28e-05 | 194 | 130 | 6 | 3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956 | |
| ToppCell | 15-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 2.28e-05 | 194 | 130 | 6 | 5c1218d239c88082496924653ed2a092dc44a906 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.28e-05 | 194 | 130 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.41e-05 | 196 | 130 | 6 | 2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 196 | 130 | 6 | 1d94cecd378a829dd8014fc086d7fca48c953a91 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 196 | 130 | 6 | aacec48285bcb7ccf1b538187071885e3602cc49 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-05 | 197 | 130 | 6 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-05 | 197 | 130 | 6 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 197 | 130 | 6 | 1c91e3afcc5be195b827a1dff83aff5cc2492456 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 198 | 130 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | distal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.55e-05 | 198 | 130 | 6 | 37ce7b485ffb207e75afd1b576b486c6d59fc136 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 198 | 130 | 6 | 3222d064b6ecab0caa450a59fc1dc79e26fc6fd5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 198 | 130 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.55e-05 | 198 | 130 | 6 | 5080767ff55326b7d94fca27d398237c4a15c1ed | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.55e-05 | 198 | 130 | 6 | e967c601101361fc1c48dab0e5b76dc68813276e | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 2.63e-05 | 199 | 130 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.63e-05 | 199 | 130 | 6 | 471738f2059e20407572d9c4cbd11812068333ea | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-05 | 199 | 130 | 6 | f1723cfd6fbb8c8903a3b167872ec8523e3be250 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.63e-05 | 199 | 130 | 6 | 706b7de777ff86eb22e538ccd5c2987ceb6be308 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | MS-Multiple_Sclerosis-Others-HSPC|Multiple_Sclerosis / Disease, condition lineage and cell class | 2.63e-05 | 199 | 130 | 6 | 7f4a22207a8b27af9a070d289e31ebd0e57af1a6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-05 | 199 | 130 | 6 | 9e32644b93fb1c4946dbe388fd5c357304d14e36 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.63e-05 | 199 | 130 | 6 | 690a4f84b205532c4c9e5c19d5ae430d0655f421 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-05 | 200 | 130 | 6 | 4fb6fd703aca9a992924245105ad99163146a415 | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.70e-05 | 200 | 130 | 6 | 5c0135d3cb6f7fa904e9760904dfe5f11c7e9102 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.70e-05 | 200 | 130 | 6 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | proximal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.70e-05 | 200 | 130 | 6 | 870ab11343711f64fe6d6a858fc420fe17f1636a | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-05 | 200 | 130 | 6 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-05 | 200 | 130 | 6 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.70e-05 | 200 | 130 | 6 | c1d9748aaae489d26e24602a5dcbe7f5fa9a5548 | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.70e-05 | 200 | 130 | 6 | 6a5047018b12be3bc4b55a64d42e52e96c624003 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.70e-05 | 200 | 130 | 6 | 1b5ac5b3ddd4df32e940531cc020998f8cd95c2c | |
| ToppCell | medial-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.70e-05 | 200 | 130 | 6 | 16b00eacbea4d75cf814803d3fc0b82c2b8c0a9c | |
| Computational | Genes in the cancer module 267. | 4.65e-06 | 15 | 85 | 4 | MODULE_267 | |
| Drug | BzATP | PTGES2 DUSP1 PRX TNFSF11 P2RX1 P2RX3 P2RX4 P2RX7 P2RX6 ENTPD2 | 1.38e-09 | 117 | 130 | 10 | CID000115205 |
| Drug | Ip5I | 4.31e-09 | 12 | 130 | 5 | CID004186342 | |
| Drug | AC1O718G | 4.31e-09 | 12 | 130 | 5 | CID000644357 | |
| Drug | KN-62 | CACNA1C MYL1 RARS1 MYLK TNFSF11 P2RX1 P2RX3 P2RX4 P2RX7 MYL6B PRKCH EIF2AK3 | 8.56e-09 | 230 | 130 | 12 | CID000003838 |
| Drug | Nf279 | 1.61e-08 | 15 | 130 | 5 | CID000004467 | |
| Drug | NSC36900 | 3.09e-08 | 56 | 130 | 7 | CID000235484 | |
| Drug | AC1NSKPI | 3.51e-08 | 57 | 130 | 7 | CID005311482 | |
| Drug | Cibacron blue-agarose | 1.18e-07 | 101 | 130 | 8 | CID000172468 | |
| Drug | AC1N5WL5 | 2.65e-07 | 76 | 130 | 7 | CID004250634 | |
| Drug | 8-SPT | 8.82e-07 | 57 | 130 | 6 | CID000001908 | |
| Drug | AC1O5RSQ | 9.99e-07 | 32 | 130 | 5 | CID006439501 | |
| Drug | Ado-5'-PP[S | 1.20e-06 | 60 | 130 | 6 | CID005310995 | |
| Drug | ATP,Gamma S | 1.44e-06 | 189 | 130 | 9 | CID000002028 | |
| Drug | arabinosyladenine | CACNA1C MYL1 VWF MYLK PFKM GRK1 P2RX1 P2RX3 P2RX4 P2RX7 P2RX6 MYL6B ENTPD2 ABCB11 PRKCH MMP2 RBFOX2 | 1.66e-06 | 762 | 130 | 17 | CID000000191 |
| Drug | Ap6A | 1.84e-06 | 36 | 130 | 5 | CID000123694 | |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.94e-06 | 196 | 130 | 9 | 848_DN | |
| Drug | Lopac-P-178 | 2.31e-06 | 67 | 130 | 6 | CID005478935 | |
| Drug | 2-methylthioadenosine triphosphate | 2.53e-06 | 68 | 130 | 6 | CID000001581 | |
| Drug | BAPTA | CACNA1C MYL1 MYLK DUSP1 SLC2A1 P2RX1 P2RX7 SACS P2RX6 MYL6B PRKCH | 2.64e-06 | 324 | 130 | 11 | CID000104751 |
| Drug | caged ATP | 3.00e-06 | 70 | 130 | 6 | CID000123806 | |
| Drug | AC1L1IO7 | 3.54e-06 | 72 | 130 | 6 | CID000000194 | |
| Drug | 3'-AMP | 3.54e-06 | 72 | 130 | 6 | CID000041211 | |
| Drug | KT5926 | 4.03e-06 | 42 | 130 | 5 | CID000122126 | |
| Drug | ATP betaS | 4.30e-06 | 162 | 130 | 8 | CID005311341 | |
| Drug | DPCPX | 4.95e-06 | 117 | 130 | 7 | CID000001329 | |
| Drug | Calcium | CACNA1C DDR1 MYLK DUSP1 CDC42BPB SLC2A1 SLC12A5 TNFSF11 P2RX3 P2RX7 BTK ABCB11 EIF2AK3 | 5.14e-06 | 493 | 130 | 13 | ctd:D002118 |
| Drug | sumatriptan | 6.56e-06 | 80 | 130 | 6 | CID000005358 | |
| Drug | sodium | CACNA1C CD2AP PFN2 WNK1 SLC2A1 SLC12A5 METAP1 AGXT2 FAH P2RX3 P2RX4 P2RX7 SACS P2RX6 ENTPD2 ABCB11 PRKCH MMP2 | 7.17e-06 | 944 | 130 | 18 | CID000000923 |
| Drug | BAPTA-AM | CACNA1C PTGES2 VWF MYLK DUSP1 MED14 TNFSF11 P2RX7 ABCB11 PRKCH | 7.31e-06 | 293 | 130 | 10 | CID000002293 |
| Drug | DMPX | 7.90e-06 | 48 | 130 | 5 | CID000099562 | |
| Drug | Evans blue dye | 8.51e-06 | 127 | 130 | 7 | CID005356750 | |
| Drug | eye gene | ADCY10 CACNA1C MYL1 RARS1 MYLK DUSP1 SLC2A1 TNFSF11 MYL6B PRKCH MMP2 | 9.08e-06 | 369 | 130 | 11 | CID000004782 |
| Drug | reactive blue 2 | 1.07e-05 | 87 | 130 | 6 | CID000656725 | |
| Drug | NSC298883 | 1.22e-05 | 89 | 130 | 6 | CID000326807 | |
| Drug | pyridoxal | 1.27e-05 | 135 | 130 | 7 | CID000001050 | |
| Drug | Adenosine Triphosphate | 1.55e-05 | 193 | 130 | 8 | ctd:D000255 | |
| Drug | AC1L1DKE | 1.55e-05 | 55 | 130 | 5 | CID000002388 | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; HL60; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 3119_UP | |
| Drug | YO-PRO-1 | 1.87e-05 | 28 | 130 | 4 | CID006439500 | |
| Drug | ADP beta S | 1.88e-05 | 96 | 130 | 6 | CID005310996 | |
| Drug | AC1L1KMJ | MYL1 VWF MYLK PFN2 CLIP1 SPTBN5 SACS MYL6B PRKCH MMP2 CTTN HCLS1 | 1.88e-05 | 476 | 130 | 12 | CID000030956 |
| Drug | WB4101 | 2.16e-05 | 29 | 130 | 4 | CID000005685 | |
| Drug | ivermectin | 2.51e-05 | 101 | 130 | 6 | CID006435110 | |
| Drug | suramin | 2.56e-05 | 207 | 130 | 8 | CID000005360 | |
| Drug | 8-phenyltheophylline | 2.80e-05 | 62 | 130 | 5 | CID000001922 | |
| Drug | Ip(5)I | 2.90e-05 | 11 | 130 | 3 | CID006324651 | |
| Drug | isoproterenol | ADCY10 CACNA1C PTGES2 MYL1 MYLK P2RX1 P2RX3 P2RX4 CLCN6 P2RX7 P2RX6 MYL6B PRKCH KLKB1 | 2.96e-05 | 669 | 130 | 14 | CID000003779 |
| Drug | benextramine | 3.22e-05 | 32 | 130 | 4 | CID000002317 | |
| Drug | AC1L1F6H | 3.30e-05 | 106 | 130 | 6 | CID000003104 | |
| Drug | glutamate | SLC25A24 CACNA1C RARS1 MYLK NTRK2 NTRK3 PFKM SLC2A1 SLC12A5 AGXT2 P2RX1 P2RX3 P2RX4 CLCN6 P2RX7 PRKCH PSPC1 | 3.46e-05 | 962 | 130 | 17 | CID000000611 |
| Drug | NF449 | 3.65e-05 | 33 | 130 | 4 | CID005310945 | |
| Drug | CH2OH | 3.65e-05 | 33 | 130 | 4 | CID000137654 | |
| Drug | phorbol acetate myristate | CACNA1C PTGES2 MYL1 CDC42BPA CAMK1D MYLK DUSP1 ETV4 SLC2A1 PRX GSPT1 TNFSF11 GSPT2 P2RX1 MYL6B PRKCH MMP2 CTTN HSPA2 EIF2AK2 EIF2AK3 | 4.34e-05 | 1399 | 130 | 21 | CID000004792 |
| Drug | SB-C | 4.71e-05 | 69 | 130 | 5 | CID005331010 | |
| Drug | Y-27632 | CACNA1C MYL1 MYLK ETV4 PFN2 GRK1 P2RX7 MYL6B PRKCH MMP2 EIF2AK3 | 4.97e-05 | 444 | 130 | 11 | CID000005711 |
| Drug | glycine | 5.38e-05 | 169 | 130 | 7 | CID000000750 | |
| Drug | blebbistatin | 5.48e-05 | 116 | 130 | 6 | CID003476986 | |
| Drug | iso-H7 | 5.79e-05 | 37 | 130 | 4 | CID000001352 | |
| Drug | AC1L1GTT | 5.93e-05 | 233 | 130 | 8 | CID000003837 | |
| Drug | potassium | CACNA1C DDR1 ISYNA1 MYL1 MYLK WNK1 SLC12A5 METAP1 P2RX3 P2RX4 CLCN6 P2RX7 SACS MYL6B PRKCH KLKB1 RBFOX2 | 6.18e-05 | 1008 | 130 | 17 | CID000000813 |
| Drug | myo-inositol | CACNA1C PTGES2 ISYNA1 MYL1 MYLK P2RX1 P2RX3 P2RX4 P2RX7 SYNJ1 P2RX6 HNRNPUL2 BTK PRKCH EIF2AK3 | 6.23e-05 | 811 | 130 | 15 | CID000000892 |
| Drug | 12-deoxyphorbol 13-isobutyrate | 7.15e-05 | 39 | 130 | 4 | CID000107855 | |
| Drug | 2-aminoethyl diphenylborinate | 9.07e-05 | 127 | 130 | 6 | CID000001598 | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.05e-04 | 188 | 130 | 7 | 4835_DN | |
| Drug | bromouridine | 1.05e-04 | 43 | 130 | 4 | CID000091494 | |
| Drug | AC1L1IZE | 1.08e-04 | 131 | 130 | 6 | CID000004799 | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.09e-04 | 189 | 130 | 7 | 1065_DN | |
| Drug | 2-azido-ATP | 1.17e-04 | 17 | 130 | 3 | CID000123645 | |
| Drug | cariporide | 1.35e-04 | 86 | 130 | 5 | CID000151172 | |
| Drug | LY294002; Down 200; 10uM; MCF7; HG-U133A | 1.36e-04 | 196 | 130 | 7 | 328_DN | |
| Drug | nifedipine | CACNA1C MYL1 VWF MYLK CD2AP SLC12A5 MYL6B PRKCH MMP2 EIF2AK3 | 1.39e-04 | 415 | 130 | 10 | CID000004485 |
| Drug | Prostaglandin E1; Up 200; 10uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 6576_UP | |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 7163_DN | |
| Drug | PF-00539758-00 [351321-34-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 6416_DN | |
| Drug | 5-(2-chlorophenyl)-2-furoic acid | 1.50e-04 | 47 | 130 | 4 | CID000784625 | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; HL60; HG-U133A | 1.54e-04 | 200 | 130 | 7 | 411_DN | |
| Drug | cyclophorine | CACNA1C MYLK USP24 TNFSF11 ABCB11 PRKCH PPIL2 MMP2 KLKB1 EIF2AK2 | 1.71e-04 | 426 | 130 | 10 | CID000002909 |
| Drug | 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid | 1.85e-04 | 206 | 130 | 7 | CID000040600 | |
| Drug | alpha,beta-methyleneadenosine 5'-triphosphate | 1.93e-04 | 4 | 130 | 2 | ctd:C002630 | |
| Drug | Nf 107 | 1.93e-04 | 4 | 130 | 2 | CID000451438 | |
| Drug | MRS2159 | 1.93e-04 | 20 | 130 | 3 | CID006258690 | |
| Drug | Nf023 | 1.93e-04 | 20 | 130 | 3 | CID005311313 | |
| Drug | lavendustin B | 2.24e-04 | 21 | 130 | 3 | CID000003895 | |
| Drug | L 360 | 2.24e-04 | 21 | 130 | 3 | CID000005512 | |
| Drug | U46619 | 2.38e-04 | 285 | 130 | 8 | CID000005618 | |
| Drug | Pilocarpine | 2.38e-04 | 285 | 130 | 8 | ctd:D010862 | |
| Disease | azoospermia (implicated_via_orthology) | 4.53e-06 | 27 | 122 | 4 | DOID:14227 (implicated_via_orthology) | |
| Disease | Child Development Disorders, Specific | 6.10e-06 | 29 | 122 | 4 | C0085997 | |
| Disease | Child Development Deviations | 6.10e-06 | 29 | 122 | 4 | C0085996 | |
| Disease | Developmental Disabilities | 7.01e-06 | 30 | 122 | 4 | C0008073 | |
| Disease | Grand Mal Status Epilepticus | 8.75e-06 | 67 | 122 | 5 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 8.75e-06 | 67 | 122 | 5 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 8.75e-06 | 67 | 122 | 5 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 8.75e-06 | 67 | 122 | 5 | C0751523 | |
| Disease | Petit mal status | 8.75e-06 | 67 | 122 | 5 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 8.75e-06 | 67 | 122 | 5 | C0393734 | |
| Disease | Malignant neoplasm of breast | FLNA RAP1GAP VWF PCDHGB6 MED14 ETV4 WNK1 CLIP1 ATP6AP1L SLC2A1 CCT5 BTK TENM1 SCP2 ZFYVE26 MMP2 | 9.39e-06 | 1074 | 122 | 16 | C0006142 |
| Disease | Status Epilepticus | 9.42e-06 | 68 | 122 | 5 | C0038220 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.11e-05 | 11 | 122 | 3 | DOID:0060669 (implicated_via_orthology) | |
| Disease | hemangioma (is_marker_for) | 1.70e-05 | 2 | 122 | 2 | DOID:255 (is_marker_for) | |
| Disease | age at assessment, pelvic organ prolapse | 3.03e-05 | 43 | 122 | 4 | EFO_0004710, EFO_0008007 | |
| Disease | hypertension (biomarker_via_orthology) | 4.60e-05 | 227 | 122 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | bipolar disorder (is_marker_for) | 6.37e-05 | 19 | 122 | 3 | DOID:3312 (is_marker_for) | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 1.15e-04 | 23 | 122 | 3 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 1.15e-04 | 23 | 122 | 3 | C0393682 | |
| Disease | Uncinate Epilepsy | 1.15e-04 | 23 | 122 | 3 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 1.15e-04 | 23 | 122 | 3 | C0014556 | |
| Disease | Idiopathic generalized epilepsy | 2.52e-04 | 6 | 122 | 2 | C0270850 | |
| Disease | Large cell carcinoma of lung | 3.13e-04 | 32 | 122 | 3 | C0345958 | |
| Disease | pulmonary venoocclusive disease (biomarker_via_orthology) | 3.51e-04 | 7 | 122 | 2 | DOID:5453 (biomarker_via_orthology) | |
| Disease | interleukin 16 measurement | 4.46e-04 | 36 | 122 | 3 | EFO_0008173 | |
| Disease | obsolete_red blood cell distribution width | DOCK8 DUSP1 CD2AP WNK1 ATP6AP1L SLC2A1 GTF2IRD2B CLCN6 CCT5 GTF2IRD2 SMG9 ABCB11 EIF2AK2 TBL2 RBFOX2 | 4.54e-04 | 1347 | 122 | 15 | EFO_0005192 |
| Disease | focal segmental glomerulosclerosis (is_marker_for) | 4.67e-04 | 8 | 122 | 2 | DOID:1312 (is_marker_for) | |
| Disease | programmed cell death 1 ligand 2 measurement | 4.67e-04 | 8 | 122 | 2 | EFO_0008268 | |
| Disease | C-reactive protein measurement | SEMA6C DOCK4 RAP1GAP DUSP1 BHMT METAP1 MST1R TNFSF11 P2RX4 P2RX7 SLC4A1AP ABCB11 TBL2 FAM177A1 | 4.72e-04 | 1206 | 122 | 14 | EFO_0004458 |
| Disease | Intellectual Disability | 5.57e-04 | 447 | 122 | 8 | C3714756 | |
| Disease | sclerostin measurement | 5.99e-04 | 9 | 122 | 2 | EFO_0010606 | |
| Disease | Mood Disorders | 6.83e-04 | 168 | 122 | 5 | C0525045 | |
| Disease | Autistic Disorder | 7.77e-04 | 261 | 122 | 6 | C0004352 | |
| Disease | alkaline phosphatase measurement | RAP1GAP ACADVL COLEC10 ATP6AP1L SLC12A5 METAP1 TNFSF11 P2RX7 SLC4A1AP ABCB11 TBL2 RIC1 | 1.04e-03 | 1015 | 122 | 12 | EFO_0004533 |
| Disease | event free survival time, type 1 diabetes mellitus, autoantibody measurement | 1.09e-03 | 12 | 122 | 2 | EFO_0000482, EFO_0004866, MONDO_0005147 | |
| Disease | Candidemia | 1.09e-03 | 12 | 122 | 2 | EFO_1001282 | |
| Disease | aminoadipic acid measurement | 1.17e-03 | 50 | 122 | 3 | EFO_0010459 | |
| Disease | QRS amplitude, QRS complex | 1.17e-03 | 50 | 122 | 3 | EFO_0005054, EFO_0007742 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 1.28e-03 | 13 | 122 | 2 | C0369183 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 1.28e-03 | 13 | 122 | 2 | C1261502 | |
| Disease | skin melanoma (is_marker_for) | 1.28e-03 | 13 | 122 | 2 | DOID:8923 (is_marker_for) | |
| Disease | serum gamma-glutamyl transferase measurement | CDC42BPA RWDD2B COLEC10 CDC42BPB BHMT METAP1 P2RX4 P2RX7 ABCB11 TBL2 BICC1 | 1.47e-03 | 914 | 122 | 11 | EFO_0004532 |
| Disease | atrial fibrillation (is_implicated_in) | 1.49e-03 | 14 | 122 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | intracranial aneurysm (is_marker_for) | 1.49e-03 | 14 | 122 | 2 | DOID:10941 (is_marker_for) | |
| Disease | Chronic Lymphocytic Leukemia | 1.55e-03 | 55 | 122 | 3 | C0023434 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.69e-03 | 206 | 122 | 5 | C0152013 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 1.72e-03 | 15 | 122 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | Breast Carcinoma | 1.82e-03 | 538 | 122 | 8 | C0678222 | |
| Disease | Pontoneocerebellar hypoplasia | 1.96e-03 | 16 | 122 | 2 | cv:C1261175 | |
| Disease | Inborn Errors of Metabolism | 2.21e-03 | 17 | 122 | 2 | C0025521 | |
| Disease | major depressive disorder (is_marker_for) | 2.21e-03 | 17 | 122 | 2 | DOID:1470 (is_marker_for) | |
| Disease | response to cyclophosphamide | 2.21e-03 | 17 | 122 | 2 | GO_1902518 | |
| Disease | Global developmental delay | 2.30e-03 | 133 | 122 | 4 | C0557874 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 2.77e-03 | 19 | 122 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | squamous cell carcinoma (is_marker_for) | 2.77e-03 | 19 | 122 | 2 | DOID:1749 (is_marker_for) | |
| Disease | serum homoarginine measurement | 3.07e-03 | 20 | 122 | 2 | EFO_0005421 | |
| Disease | Malignant Glioma | 3.09e-03 | 70 | 122 | 3 | C0555198 | |
| Disease | mixed gliomas | 3.09e-03 | 70 | 122 | 3 | C0259783 | |
| Disease | mean platelet volume | VWF ZAN PCDHGB6 DOCK8 CD2AP CDC42BPB SHANK3 TXK FAH COCH P2RX1 | 3.42e-03 | 1020 | 122 | 11 | EFO_0004584 |
| Disease | leucine measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0009770 | |
| Disease | amblyopia | 3.71e-03 | 22 | 122 | 2 | MONDO_0001020 | |
| Disease | Nasopharyngeal carcinoma | 3.71e-03 | 22 | 122 | 2 | C2931822 | |
| Disease | Carcinoma of lung | 4.05e-03 | 23 | 122 | 2 | C0684249 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 4.05e-03 | 23 | 122 | 2 | DOID:0050156 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GFLKEAFELVRARGG | 301 | Q9BYV1 | |
| EIVIGDGGFVFALEK | 21 | Q93088 | |
| EKFGRGVIAGLVDIG | 76 | Q8TE69 | |
| EKFGRGVIAGLVDIG | 76 | Q96DE9 | |
| RGGFGVVFEAKNKVD | 601 | Q9NZJ5 | |
| KQEGKEGGFIVRDSS | 296 | Q06187 | |
| RFKEKLGEGQFGEVH | 611 | Q08345 | |
| DEKKGDGVRVGFFQL | 36 | O95342 | |
| KSGFFRVFIGVNDLE | 201 | Q9Y6Z7 | |
| RQGKFEVTIFDLGGG | 61 | Q3SXY8 | |
| IRGIGFGDIFKEGSV | 211 | Q9Y5K6 | |
| VLIFGGDILKFAGDA | 86 | Q96PN6 | |
| FFGGVSGLTVEQFRK | 271 | O43286 | |
| KEEKVFLGGGAVEFL | 531 | Q6ZW61 | |
| AEGKGRSGEDFFQKI | 66 | Q9H694 | |
| KFEGDIKQEGVGAFR | 316 | P43268 | |
| DGIAQIRGEIFFFKD | 476 | P08253 | |
| RYGKDFGAIAEVIGN | 346 | Q8IZ40 | |
| SKQGFIGAGRRAKED | 371 | Q5T481 | |
| DKKHTIFGRVVGGFD | 391 | Q13356 | |
| GIRFDIIVFGKAGKF | 316 | Q99571 | |
| EIIFNERGSKGFGFV | 151 | O43251 | |
| DGFAVVFNDGKVGFI | 216 | Q4ADV7 | |
| RVFVGGDDFKSGQTK | 296 | Q9NPH2 | |
| FEILKVIGRGAFGEV | 71 | Q6DT37 | |
| VALFKTRDLDFGGNG | 366 | Q9Y5F9 | |
| ARTENVKGFFGGLET | 236 | O60268 | |
| LEGGRAFFNAVKEGD | 586 | Q9ULU8 | |
| IEERLGSGKFGQVFR | 1466 | Q15746 | |
| AFKFDVVDGEGNRLI | 2171 | Q86XX4 | |
| VLEFLGRGTFGQVVK | 201 | Q9H2X6 | |
| FFVGEVDDGARKLVQ | 236 | P53582 | |
| VGFKKSRDVFGLDFG | 356 | Q8N653 | |
| GFDVAKTGDARIGFV | 56 | Q9Y295 | |
| ERGFENVELGVIGKK | 36 | Q8N128 | |
| KRELGEGAFGKVFLA | 541 | Q16288 | |
| KGRTFDEIASGFRQG | 456 | P11166 | |
| DERAFGGVIFQKKAA | 416 | Q9Y5L3 | |
| KGEFETGFEKGGQTR | 316 | Q8IYD1 | |
| RKEGGKFGFAESIAN | 276 | Q06265 | |
| KNVLIFDLGGGTFDV | 196 | P54652 | |
| EIFFGKTRNGGGDVD | 156 | P80217 | |
| EEGKGIFDSRKNVLG | 646 | P08237 | |
| DEVRFVFGGAFLKGD | 456 | Q6NT32 | |
| IFVGEDAVDAGGVRK | 741 | Q5GLZ8 | |
| FDGRGLKAENGQFEE | 336 | Q1KMD3 | |
| GGGVHLFQKFVEERD | 331 | O95568 | |
| DFVEGLRVFDKEGNG | 131 | P05976 | |
| FEIIKVIGRGAFGEV | 76 | Q9Y5S2 | |
| LKGVLVRNGGSFEDD | 101 | P28290 | |
| RKGEFETGFEKGGQT | 186 | P15170 | |
| DFQAFGVKGGRRINE | 606 | Q9P2V4 | |
| TVANGRVKFRVEGEF | 216 | O60244 | |
| LENGDGDKEKTGVRF | 151 | P35227 | |
| IVGKDREGFFTNGLT | 51 | P35080 | |
| FGDEDFQLKFEGRVG | 1431 | Q5VYJ5 | |
| RFDILVFGTGGKFDI | 316 | Q99572 | |
| SGGAVFKKDDIGRRN | 86 | P57076 | |
| GVLFSVAGGLFVEKE | 186 | P51797 | |
| GKGAGFDVKALRAFR | 226 | Q13936 | |
| GEFEKGGKSVARNVE | 411 | Q8N1I0 | |
| RVGFFGSKFGDLDEQ | 1796 | Q8NF50 | |
| IDFIDSIKNAGGRVF | 241 | P28562 | |
| DFKEIELIGSGGFGQ | 266 | P19525 | |
| FQAEEKGVRVLGGDR | 181 | I3L3R5 | |
| ERVKQKDLGDGVYGF | 526 | P21333 | |
| DFGGEELNVTFVKGV | 301 | P03952 | |
| GNGQTRKFLLDGDEV | 376 | P16930 | |
| GLFEKLRGGRAGFAD | 471 | Q6ZRV2 | |
| GQNRFEEVDLILKGG | 446 | Q6UWX4 | |
| LDFRVLGKGGFGEVS | 191 | Q15835 | |
| FTEFRVLGKGGFGEV | 191 | Q8WTQ7 | |
| VNDLFSRKFGEAIGV | 336 | Q86UP8 | |
| VNDLFSRKFGEAIGV | 336 | Q6EKJ0 | |
| KDVLFAIKEVGFRGG | 226 | O43405 | |
| FTEDDVRGIQNLGKG | 2596 | Q9NZJ4 | |
| GVVRFLGETDFAKGE | 226 | P30622 | |
| LRVGDVVKFAGQDFA | 216 | P56373 | |
| FRIGDLVAKAGGTFE | 241 | O15547 | |
| EGVVLRDKFGEAVNG | 481 | Q9H2X9 | |
| RDKFGEAVNGNLVVG | 486 | Q9H2X9 | |
| FGIRFDILVDGKAGK | 311 | P51575 | |
| VFHAGFGVVLGEDKK | 436 | P54136 | |
| VEIIFNERGSKGFGF | 146 | Q9NWB1 | |
| VTFIVDGAVVKFGQG | 111 | Q9H5V9 | |
| AGQVFRGFLEGKVTF | 766 | O43426 | |
| AAKGFGGKYGVERDR | 116 | P14317 | |
| GDVDFEGVRQKAGYI | 291 | P13995 | |
| FERDIKGESLFQGRG | 226 | P09758 | |
| VKLQDFKGFRGGLDV | 231 | P47736 | |
| KERGGNQTSGIDFFI | 246 | Q9H0W8 | |
| EKLGFAGLVQEISFG | 351 | P48643 | |
| FQKGRAIDTGEVDIG | 391 | Q9UKZ4 | |
| REGKFGAVEGAVAKY | 266 | Q9H7Z7 | |
| EEGEQFVKKIGGIFA | 446 | P22307 | |
| DFEILKVIGRGAFGE | 76 | Q5VT25 | |
| VSGGELFDRIVEKGF | 101 | Q8IU85 | |
| EGLELQKFGREVDGF | 1206 | Q9NRC6 | |
| KEKITAFVVERGFGG | 276 | P49748 | |
| QGKVEVEVGKEGLRF | 676 | Q9NRU3 | |
| VEVGKEGLRFENGAF | 681 | Q9NRU3 | |
| KRELGEGAFGKVFLA | 541 | Q16620 | |
| GGEIELFDGEVNVKR | 931 | P04275 | |
| LGELKRFFEAAAGSG | 96 | Q96FF7 | |
| YLEGFRVFDKEGNGK | 146 | P14649 | |
| KRDHEGFGFVLRGAK | 576 | Q9BYB0 | |
| DRGRATGKGFVEFAA | 191 | Q8WXF1 | |
| GFGGKFGVQTDRQDK | 231 | Q14247 | |
| GISFRGGQKAEVIDK | 466 | Q5TCZ1 | |
| FGLARGKEAEVQGDR | 1066 | Q9BXM0 | |
| FGLVRAKEGAEEGEK | 1311 | Q9BXM0 | |
| GRFLAVGVLEGKKFE | 301 | Q9UHP3 | |
| RGFEGKFKEQRSLDG | 341 | Q9H3T2 | |
| GELIDRFVADFKAQG | 441 | Q5VIR6 | |
| IFEEKVFSVNGARGN | 276 | P57060 | |
| NVGGFFKLRSGEEIS | 276 | O14788 | |
| LAFIKEIGSGQFGVV | 271 | P42681 | |
| VVDLVNKFGELGGFA | 281 | Q9UPU5 | |
| FGRLFGREFVDSGEK | 176 | P04628 | |
| RELKQLIQGEFGDFF | 31 | Q5QJ38 | |
| NDGRFLKFDIEIGRG | 216 | Q9H4A3 | |
| FLEETLGGRGKFENL | 96 | Q3SY77 | |
| IDFQIQGFAIKGGRF | 121 | Q52LC2 | |
| GKNVEDGFGIAFRVL | 2381 | Q68DK2 | |
| EGQEVLFGVFVTGKD | 341 | Q04912 | |
| EEGQKIGTFERFISG | 281 | Q6NUK1 | |
| GKKGEFQEVVRAFEL | 261 | Q9Y4P3 | |
| KGVFLGASGRFVELQ | 1246 | Q9Y493 | |
| KFIAEGIIDQGGGFR | 531 | Q5T447 | |
| EGEFKNGRVDGFGLL | 86 | Q8NDC4 | |
| GIDNFEFIRVLGKGS | 351 | P24723 | |
| KKALQGFFDREGEEL | 371 | Q9BWU0 | |
| AVELEERGQKRVGFG | 91 | Q5VTT5 |